LFMD Stock Overview
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men’s sexual health, dermatology, and others in the United States.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$2.16|
|52 Week High||US$13.10|
|52 Week Low||US$1.80|
|1 Month Change||-4.00%|
|3 Month Change||-37.39%|
|1 Year Change||-82.93%|
|3 Year Change||292.73%|
|5 Year Change||44.00%|
|Change since IPO||-18.49%|
Recent News & Updates
|LFMD||US Personal Products||US Market|
Return vs Industry: LFMD underperformed the US Personal Products industry which returned -21.3% over the past year.
Return vs Market: LFMD underperformed the US Market which returned -18.5% over the past year.
|LFMD Average Weekly Movement||12.5%|
|Personal Products Industry Average Movement||11.0%|
|Market Average Movement||8.0%|
|10% most volatile stocks in US Market||16.6%|
|10% least volatile stocks in US Market||3.1%|
Stable Share Price: LFMD is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week.
Volatility Over Time: LFMD's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men’s sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men’s telehealth brand that offers virtual medical treatment from licensed providers for a variety of men’s health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers.
LifeMD Fundamentals Summary
|LFMD fundamental statistics|
Is LFMD overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|LFMD income statement (TTM)|
|Cost of Revenue||US$20.03m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-2.09|
|Net Profit Margin||-61.94%|
How did LFMD perform over the long term?See historical performance and comparison
Is LFMD undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 3/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for LFMD?
Other financial metrics that can be useful for relative valuation.
|What is LFMD's n/a Ratio?|
Price to Sales Ratio vs Peers
How does LFMD's PS Ratio compare to its peers?
|LFMD PS Ratio vs Peers|
|Company||PS||Estimated Growth||Market Cap|
Price-To-Sales vs Peers: LFMD is good value based on its Price-To-Sales Ratio (0.6x) compared to the peer average (7.9x).
Price to Earnings Ratio vs Industry
How does LFMD's PE Ratio compare vs other companies in the U.S. Personal Products Industry?
Price-To-Sales vs Industry: LFMD is good value based on its Price-To-Sales Ratio (0.6x) compared to the US Personal Products industry average (1.4x)
Price to Sales Ratio vs Fair Ratio
What is LFMD's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||0.6x|
|Fair PS Ratio||1.5x|
Price-To-Sales vs Fair Ratio: LFMD is good value based on its Price-To-Sales Ratio (0.6x) compared to the estimated Fair Price-To-Sales Ratio (1.5x).
Share Price vs Fair Value
What is the Fair Price of LFMD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate LFMD's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate LFMD's fair value for valuation analysis.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate LFMD's PEG Ratio to determine if it is good value.
Discover undervalued companies
How is LifeMD forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Future Growth Score2/6
Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LFMD is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: LFMD is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: LFMD is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: LFMD's revenue (25.6% per year) is forecast to grow faster than the US market (8.4% per year).
High Growth Revenue: LFMD's revenue (25.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if LFMD's Return on Equity is forecast to be high in 3 years time
Discover growth companies
How has LifeMD performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: LFMD is currently unprofitable.
Growing Profit Margin: LFMD is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: LFMD is unprofitable, and losses have increased over the past 5 years at a rate of 71.5% per year.
Accelerating Growth: Unable to compare LFMD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LFMD is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (37.3%).
Return on Equity
High ROE: LFMD has a negative Return on Equity (-383.53%), as it is currently unprofitable.
Discover strong past performing companies
How is LifeMD's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: LFMD's short term assets ($29.6M) exceed its short term liabilities ($25.6M).
Long Term Liabilities: LFMD's short term assets ($29.6M) exceed its long term liabilities ($8.3M).
Debt to Equity History and Analysis
Debt Level: LFMD has more cash than its total debt.
Reducing Debt: LFMD had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LFMD has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if LFMD has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Discover healthy companies
What is LifeMD current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate LFMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate LFMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if LFMD's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if LFMD's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as LFMD has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Justin Schreiber (38 yo)
Mr. Justin Schreiber served as an Independent Director at Quantum Computing Inc until September 22, 2021. Mr. Schreiber has been Chairman of the Board at LifeMD, Inc. (formerly known as Conversion Labs, In...
CEO Compensation Analysis
Compensation vs Market: Justin's total compensation ($USD180.00K) is below average for companies of similar size in the US market ($USD752.25K).
Compensation vs Earnings: Justin's compensation has been consistent with company performance over the past year.
Experienced Management: LFMD's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Experienced Board: LFMD's board of directors are considered experienced (3.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: LFMD insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.9%.
LifeMD, Inc.'s employee growth, exchange listings and data sources
- Name: LifeMD, Inc.
- Ticker: LFMD
- Exchange: NasdaqGM
- Founded: 1994
- Industry: Personal Products
- Sector: Household
- Implied Market Cap: US$66.520m
- Shares outstanding: 30.80m
- Website: https://www.lifemd.com
Number of Employees
- LifeMD, Inc.
- 236 Fifth Avenue
- Suite 400
- New York
- New York
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/26 00:00|
|End of Day Share Price||2022/06/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.